BPC-157 has a large following based on animal research and user reports
Further clinical trials are necessary to determine the appropriate dosage, efficacy, and safety of loperamide in patients with PTB
Animal studies have shown a low acute toxicity profile
Moreover, we excluded patients and controls who suffered from neurodegenerative and neuroinflammatory disorders, such as chronic fatigue syndrome [54], Parkinsons or Alzheimers disease, multiple sclerosis, stroke, or systemic (auto)immune diseases such as diabetes mellitus, psoriasis, rheumatoid arthritis, inflammatory bowel disease and scleroderma, and liver and renal disease
Cenexa Labs has no affiliation with Professor Sikiric or the University of Zagreb, and this information does not constitute an endorsement of any products or services
What causes lower platelet count